
Keywords: IIV-HD; high-dose inactivated influenza vaccine; CI; confidence interval; IIV-SD; standard-dose inactivated influenza vaccine; SAE; serious adverse event; COPD; chronic obstructive pulmonary disease; RR; rate ratios; rVE; relative vaccine effectiveness; F